Development and validation of CT-based fusion model for preoperative prediction of invasion and lymph node metastasis in adenocarcinoma of esophagogastric junction

开发和验证基于CT的融合模型,用于食管胃交界处腺癌术前侵袭和淋巴结转移的预测。

阅读:1

Abstract

PURPOSE: In the context of precision medicine, radiomics has become a key technology in solving medical problems. For adenocarcinoma of esophagogastric junction (AEG), developing a preoperative CT-based prediction model for AEG invasion and lymph node metastasis is crucial. METHODS: We retrospectively collected 256 patients with AEG from two centres. The radiomics features were extracted from the preoperative diagnostic CT images, and the feature selection method and machine learning method were applied to reduce the feature size and establish the predictive imaging features. By comparing the three machine learning methods, the best radiomics nomogram was selected, and the average AUC was obtained by 20 repeats of fivefold cross-validation for comparison. The fusion model was constructed by logistic regression combined with clinical factors. On this basis, ROC curve, calibration curve and decision curve of the fusion model are constructed. RESULTS: The predictive efficacy of fusion model for tumour invasion depth was higher than that of radiomics nomogram, with an AUC of 0.764 vs. 0.706 in the test set, P < 0.001, internal validation set 0.752 vs. 0.697, P < 0.001, and external validation set 0.756 vs. 0.687, P < 0.001, respectively. The predictive efficacy of the lymph node metastasis fusion model was higher than that of the radiomics nomogram, with an AUC of 0.809 vs. 0.732 in the test set, P < 0.001, internal validation set 0.841 vs. 0.718, P < 0.001, and external validation set 0.801 vs. 0.680, P < 0.001, respectively. CONCLUSION: We have developed a fusion model combining radiomics and clinical risk factors, which is crucial for the accurate preoperative diagnosis and treatment of AEG, advancing precision medicine. It may also spark discussions on the imaging feature differences between AEG and GC (Gastric cancer).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。